Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds.
Luís Prats-SánchezPol Camps-RenomPhilip S NashDuncan WilsonGareth AmblerJonathan G BestMarina Guasch-JiménezAnna Ramos-PachonAlejandro Martinez-DomeñoÁlvaro Lambea-GilGarbiñe Ezcurra DíazDaniel Guisado-AlonsoHou-Wei DuRustam Al-Shahi SalmanHans Rolf JägerGregory Yoke Hong LipHakan AySimon JungNatan M BornsteinThomas GattringerSebastian EppingerDianne H K van Dam-NolenMasatoshi KogaKazunori ToyodaFelix FluriThanh G PhanVelandai K SrikanthJi-Hoe HeoHee Joon BaePeter J KellyToshio ImaizumiJulie StaalsSebastiaan KöhlerYusuke YakushijiDilek Necioglu OrkenEric Edward SmithJoanna Marguerite WardlawFrancesca M ChappellStephen D J MakinJean-Louis MasDavid CalvetRegis BordetChristopher Li Hsian ChenRoland VeltkampNagaendran KandiahRobert J SimisterFrank-Erik De LeeuwStefan T EngelterNils PetersYannie Oy SooAnnaelle ZietzJeroen HendrikseWerner H MessDavid John WerringJoan Martí-Fàbregasnull nullPublished in: Neurology (2024)
This study provides Class III evidence that for patients with IS or TIA and CMBs, statins lower the risk of any stroke or IS without increasing the risk of ICrH.